Posts
- The Autolomous experience – by Ryan Leung (Intern) - 1 June 2021
- BIA Women in Biotech event - 9 March 2023
- Fraser Dove International – Lift up: Allyship in Action, Building Leaders & Followers for the Future - 17 April 2025
- Citeline – Scrip Asks – What Does 2026 Hold For Biopharma? Part 5: AI And Operational Excellence - 11 February 2026
- Privacy Policy - 1 January 2019
- Supporting Bio-Techne’s CGT manufacturing capabilities - 10 June 2021
- Made Smarter Innovation CR&D Project Showcase - 21 March 2023
- The Pharma Navigator – Unlocking the Potential of Next-Gen Therapies with Advanced Technology - 4 June 2025
- Cell & Gene Therapy Review – Jan/Feb/March 2026 edition - 27 February 2026
- Glycostem Therapeutics commercial contract - 3 June 2020
- Autolomous collaboration awarded UK Research & Innovation grant - 27 July 2021
- Autolomous’ Strategic Advisory Board - 25 May 2023
- Discover Pharma – Unlocking collective intelligence - 10 June 2025
- Autolomous Supports the Blood Centers of America Advanced Therapies Workshop - 2 March 2026
- CMS advises Autolomous on fundraising - 5 August 2020
- Steven Binninger appointed as Head of Process Science and Technology - 7 September 2021
- Autolomous & CGT Catapult awarded £1.2M grant by UKRI - 12 June 2023
- Technology Networks – Biopharma – European Pharma Experts React to US Tariff Uncertainty - 12 June 2025
- Autolomous Attends Scaling CAR-T Therapies: Clinical Delivery, Workforce and System Readiness at UWE Bristol - 5 March 2026
- GEN article – Boosting CGT bioprocessing capabilities - 17 November 2020
- Single Sign-On with Okta (Michal Woznica, Senior Dev) - 22 September 2021
- Five Years of Impact – Celebrating Autolomous’ Anniversary - 6 February 2024
- PharmTech – Behind the Headlines, Episode 19: CGT Cost Pressures, BioNTech’s CureVac Move, and Spain’s CAR-T Model - 19 June 2025
- BioSpectrum Asia – Europe At A Biotech Crossroads As Digital Gaps Challenge Global Ambitions - 9 March 2026
- Forbes insight into challenges faced by CGT - 11 December 2020
- Autolomous: ISO 9001:2015 & ISO 27001:2013 certified - 8 October 2021
- Information Security, Quality & Sustainability - 11 April 2024
- Discover Pharma – Unlocking collaboration: How data sharing and digital innovation are shaping the future of cell and gene therapy manufacturing - 1 July 2025
- Autolomous Attends ELRIG Cell and Gene Therapy 2026 - 9 March 2026
- ARM 2020 report: $19.9B invested in industry - 16 March 2021
- Autolomous and Vineti form strategic partnership to deliver end to end solutions - 18 October 2021
- Autolomous & BioCentriq Partner to Speed Up Cell Therapy Delivery - 23 May 2024
- Technology Networks – What Skills Do the Next Generation of Scientists Need? - 4 July 2025
- Autolomous Attends Advanced Therapies (London, UK) - 16 March 2026
- Autolomous included in industry supplier review - 1 April 2021
- My internship notes – by Ryan Leung (Intern) - 25 November 2021
- autoloMATE® Launchpad - 28 May 2024
- CGT Catapult and Autolomous showcase benefits of digital technologies in advanced therapy manufacturing - 6 October 2025
- Autolomous appoints Chief Business Officer (CBO) - 21 April 2026
- ARM’s Meeting on the Med 2021 event - 6 April 2021
- Autolomous selected by RFL NHS Trust to lead their digitalization program - 10 December 2021
- Autolomous releases the CGT industry’s first free eBR Builder, autoloMATE Launchpad, to empower digital planning - 29 May 2024
- Adva Biotechnology and Autolomous Launch the Digital PIONEER Program to Enable Decentralized, Scalable Cell Therapy Manufacturing — GenCART Inc. Joins as First Clinical Participant - 6 October 2025
- Autolomous expands digital orchestration solutions from CGT to wider biopharma sectors - 6 May 2026
- In the press – BioProcess International discussion - 27 April 2021
- InfoSec Overview - 15 December 2021
- Advanced Therapies Week 2025 – Leading the Way in Advanced Therapies: A Fireside Chat on Act for Hope - 21 January 2025
- IBTV – Autolomous CEO Alexander Seyf talks to IBTV at ARM / Cell & Gene’s Meeting on the Mesa 2025 – CGT Catapult - 19 October 2025
- autoloMATE® Launchpad - 8 June 2026
- Innovate UK supports delivery of AutoloMATE Assist - 4 May 2021
- The AutoloMATE® platform brochure - 15 December 2021
- Citeline Scrip Asks: What Does 2025 Hold For Biopharma? - 24 January 2025
- IBTV – Autolomous CEO Alexander Seyf talks to IBTV at ARM / Cell & Gene’s Meeting on the Mesa 2025 – Adva & GenCART - 19 October 2025
- Expediting Batch Verification Digitization - 5 May 2021
- Autolomous to provide digital solutions to Center for Breakthrough Medicines - 12 January 2023
- BioPharm International: Innovation Accelerates into the Future - 12 February 2025
- Autolomous 2025 Christmas Party – A Festive Celebration! - 11 December 2025
- Autolomous receives loan from UKRI - 5 May 2021
- CBM-Autolomous collaboration - 25 January 2023
- Medical Device Network: Cybersecurity in Healthcare - 17 March 2025
- Giving Back: Autolomous Volunteering Day 2025 - 31 December 2025
- Advanced Therapies Congress & Expo 2021 - 5 May 2021
- The #autoloMATEs series – Alexa - 1 February 2023
- IBTV: Alexander Seyf, CEO of Autolomous Talks to IBTV at Terrapinn’s Advanced Therapies 2025 - 18 March 2025
- Why Interoperability Is Key to Unlocking Progress in CGT - 15 January 2026
- The ISCT 2021 Virtual Annual Meeting - 8 May 2021
- 4 years of making a difference - 6 February 2023
- PharmTech: Industry Outlook 2025: Business Viability and Global Collaboration - 31 March 2025
- Cell & Gene Therapy Review – 2026 cell and gene therapy predictions - 9 February 2026
- Manufacturing digital solution for Achilles Therapeutics - 19 May 2021
- The #autoloMATEs series – Walid - 20 February 2023
- PharmTech: Industry Outlook 2025: Technology as a Supporting Element - 14 April 2025
- autoloMATE® Services Overview - 11 February 2026
Jobs
- Strategic Solutions Architect - 17 November 2025
- Business Analyst - 17 November 2025
- Junior UX/UI Designer - 18 November 2025
- Project Manager - 18 November 2025
- Software QA - 26 January 2026
- Software Developer - 14 May 2026